Treatment of Urticaria (Hives) in Children
H1 antihistamines are the mainstay of treatment for urticaria in children, with second-generation non-sedating antihistamines being the first-line therapy. 1
First-Line Treatment
Second-generation H1 antihistamines (non-sedating) are the cornerstone of urticaria management in children due to their efficacy in controlling symptoms with minimal side effects 1, 2
For children who don't respond adequately to standard doses, increasing the dose of second-generation H1 antihistamines above the manufacturer's licensed recommendation may be considered when benefits outweigh risks 1
Second-Line and Adjunctive Treatments
For cases resistant to standard doses of second-generation antihistamines, consider these approaches:
- Combination therapy with H1 and H2 antihistamines (such as ranitidine or famotidine) can be effective for controlling severe pruritus and wheal formation 1
- Addition of a sedating antihistamine (such as diphenhydramine or hydroxyzine) at night can help with sleep disruption from pruritus 1
- Leukotriene receptor antagonists (e.g., montelukast) may be added as adjunctive therapy for resistant cases 1, 2
Short courses of oral corticosteroids should be restricted to severe acute urticaria or angioedema affecting the mouth 1, 3
- The evidence for adding corticosteroids to antihistamines in acute urticaria is mixed, with most studies showing no additional benefit 3
Management Considerations
Cooling antipruritic lotions, such as calamine or 1% menthol in aqueous cream, can provide symptomatic relief 1
For urticaria associated with mastocytosis, temperature control is particularly important as mast cells can be activated by hot and cold temperatures 1
Special Considerations
Duration of individual wheals is diagnostically important:
Most cases of acute urticaria resolve within 6 months, but those with both wheals and angioedema may have a more prolonged course 1
Treatment-Resistant Cases
For chronic urticaria unresponsive to optimal antihistamine therapy, referral to a specialist may be necessary for consideration of:
Immunomodulating therapies should be restricted to patients with disabling disease who have not responded to conventional treatments 1
Pitfalls and Caveats
- Avoid first-generation H1 antihistamines as first-line therapy due to their sedative effects, which can impact school performance and cognitive function 1
- NSAIDs should be avoided in aspirin-sensitive patients with urticaria due to risk of cross-reactions 1
- Extensive laboratory workup is unnecessary for most cases of urticaria unless specific underlying conditions are suggested by history or physical examination 2
- Remember that chronic urticaria is idiopathic in 80-90% of cases, so focusing on symptom management rather than extensive testing for causes is often more beneficial 2